Mini Review
Volume 3 Issue 2 - 2020
Is Lipedema a Unique Entity?
Alexandre Campos Moraes Amato1,2*
1Professor of Vascular Surgery, University of Santo Amaro, São Paulo, SP, Brazil
2Chief of Vascular Surgery, Amato - Instituto de Medicina Avançada, São Paulo, SP, Brazil
*Corresponding Author: Alexandre Campos Moraes Amato, Professor of Vascular Surgery, University of Santo Amaro, São Paulo and Chief of Vascular Surgery, Amato - Instituto de Medicina Avançada, São Paulo, SP, Brazil.
Received: January 09, 2019; Published: January 28, 2020




Abstract

Lipedema is a disease with high prevalence but low recognition. It is often misdiagnosed and underdiagnosed. Obesity and lymphoedema are the most common differential diagnoses and can also coexist in patient with lipedema. Its broad range of presentation and fat distribution types contribute to this confusion. It is likely that lipedema symptom variations and presentation forms are often associated with hormonal variations, chronic low-grade systemic inflammation, and wide polygenic variations. This paper presents a theory regarding the clinical evolution of lipedema clinical and its involvement with other diseases, suggesting a three-phase approach for treatment.

Keywords: Lipedema; Obesity; Lymphoedema

References

  1. Wold L., et al. “Lipedema of the legs: a syndrome characterized by fat legs and edema”. Annals of Internal Medicine 34 (1951): 1243-1250.
  2. Allen EV., et al. “Lipedema of the legs: a syndrome characterized by fat legs and orthostatic edema”. Proceedings of the staff meetings of the Mayo Clinic 15 (1940): 184-187.
  3. Buck DW and Herbst KL. “Lipedema: A Relatively Common Disease with Extremely Common Misconceptions”. Plastic and Reconstructive Surgery – Global Open 4 (2016): e1043.
  4. Campos Moraes Amato A and Benitti DA. “Lipedema”. In: SECAD (2018): 1-22.
  5. Moraes IN. “Cânones da beleza”. Rev Cult e Saude 1 (2003): 25-30.
  6. Goodliffe JM., et al. “An under-diagnosed cause of leg swelling”. British Medical Journal Case Reports (2013)”. 
  7. Child AH., et al. “Lipedema: An inherited condition”. American Journal of Medical Genetics Part A 152 (2010): 970-976.
  8. Rapprich S., et al. “Liposuktion ist eine wirksame Therapie beim Lipödem - Ergebnisse einer Untersuchung mit 25 Patientinnen”. Journal of the German Society of Dermatology 9 (2011): 33-41.
  9. McClellan J and King MC. “Genetic heterogeneity in human disease”. Cell 141 (2010): 210-217.
  10. Hofuku I., et al. “An introduction of the node-clustering algorithm using the PH algorithm”. Inf 16 (2013): 8597-8610.
  11. Bano G., et al. “Pit-1 Mutation and Lipoedema in a Family”. Experimental and Clinical Endocrinology and Diabetes 118 (2009): 377-380.
  12. Szél E., et al. “Pathophysiological dilemmas of lipedema”. Medical Hypotheses 83 (2014): 599-606.
  13. Calvano SE., et al. “A network-based analysis of systemic inflammation in humans”. Nature 437 (2005): 1032-1037.
  14. Guthrie GJK., et al. “The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer”. Critical Reviews in Oncology/Hematology 88 (2013): 218-230.
  15. Dolan RD., et al. “The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: Comparison of composite ratios and cumulative scores”. British Journal of Cancer 119 (2018): 40-51.
  16. McMillan DC. “The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer”. Cancer Treatment Reviews 39 (2013): 534-540.
  17. Mathur N and Pedersen BK. “Exercise as a mean to control low-grade systemic inflammation”. Mediators of Inflammation (2008).
  18. Pedersen BK and Saltin B. “Evidence for prescribing exercise as therapy in chronic disease”. Scandinavian Journal of Medicine and Science in Sports 16 (2006): 3-63.
  19. Alwardat N., et al. “The effect of lipedema on health-related quality of life and psychological status: a narrative review of the literature”. Eating and Weight Disorders (2019): 1-6.
  20. LaMonte MJ., et al. “Physical activity and diabetes prevention”. Journal of Applied Physiology 99 (2005): 1205-1213.
  21. Thune I and Furberg A-S. “Physical activity and cancer risk: dose-response and cancer, all sites and site-specific”. Medicine and Science in Sports and Exercise 33 (2001): S530-S550.
  22. Wilund KR. “Is the anti-inflammatory effect of regular exercise responsible for reduced cardiovascular disease?”. Clinical Science 112 (2007): 543-555.
  23. Pedersen BK. “State of the Art Reviews: Health Benefits Related to Exercise in Patients With Chronic Low-Grade Systemic Inflammation”. American Journal of Lifestyle Medicine 1 (2007): 289-298.
  24. Petersen AMW and Pedersen BK. “The anti-inflammatory effect of exercise”. Journal of Applied Physiology 98 (2005): 1154-1162.
  25. Febbraio MA and Pedersen BK. “Contraction-induced myokine production and release: is skeletal muscle an endocrine organ?”. Exercise and Sport Sciences Reviews 33 (2005): 114-119.
  26. Pedersen BK., et al. “Searching for the exercise factor: is IL-6 a candidate?”. Journal of Muscle Research and Cell Motility 24 (2003): 113-119.
  27. Edwards KM., et al. “The Acute Stress-Induced Immunoenhancement Hypothesis”. Exercise and Sport Sciences Reviews (2007): 150-155.
  28. Bruunsgaard H. “Physical activity and modulation of systemic low-level inflammation”. Journal of Leukocyte Biology 78 ( 2005): 819-835.
  29. Gil A., et al. “Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity”. British Journal of Nutrition 98 (2007): 121-126.
  30. Bulló M., et al. “Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression”. Obesity Research 11 (2003): 525-531.
  31. Coppack SW. “Pro-inflammatory cytokines and adipose tissue”. Proceedings of the Nutrition Society 60 (2001): 349-356.
  32. Zeyda M., et al. “Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production”. International Journal of Obesity 31 (2007): 1420-1428.
  33. Dandona P., et al. “Inflammation the link between insulin resistance”. Trends in Immunology 25 (2004): 4-7.
  34. Gleeson MM. “Immune function in sport and exercise”. Journal of Applied Physiology 103 (2007): 693-699.
  35. Pedersen BK and Fischer CP. “Physiological roles of muscle-derived interleukin-6 in response to exercise”. Current Opinion in Clinical Nutrition and Metabolic Care 10 (2007): 265-271.
  36. Alexandraki K., et al. “Inflammatory process in type 2 diabetes: The role of cytokines”. Annals of the New York Academy of Sciences 1084 (2006): 89-117.
  37. Van Guilder GP., et al. “Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults”. Obesity 14 (2006): 2127-2131.
  38. Bennet AM., et al. “Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction”. Atherosclerosis 171 (2003): 359-367.
  39. Cook NR., et al. “The effect of including C-reactive protein in cardiovascular risk prediction models for women”. Annals of Internal Medicine 145 (2006): 21-29.
  40. Cholesterol CPL., et al. “Cholesterol Levels in the Prediction of First Cardiovascular Events”. The New Zealand Medical Journal 347 (2002): 1557-1565.
  41. Van Hall G., et al. “Interleukin-6 stimulates lipolysis and fat oxidation in humans”. The Journal of Clinical Endocrinology and Metabolism 88 (2003): 3005-3010.
  42. Petersen EW. “Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro”. American Journal of Physiology-Endocrinology and Metabolism 288 (2004): E155-E162.
  43. Duncan BB., et al. “Low-Grade Systemic Inflammation and the Development of Type 2 Diabetes: The Atherosclerosis Risk in Communities Study”. Diabetes 52 (2003): 1799-1805.
  44. Trayhurn P and Beattie JH. “Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ”. Proceedings of the Nutrition Society 60 (2001): 329-339.
  45. Uysal KT., et al. “Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function”. Nature 389 (1997): 610-614.
  46. Steinberg HO., et al. “Obesity/insulin resistance is associated with endothelial dysfunction: Implications for the Syndrome of Insulin Resistance”. Journal of Clinical Investigation 97 (1996): 2601-2610.
  47. Mochida-Nishimura K., et al. “Differential Activation of Map Kinase Signaling Pathways and Nuclear Factor-Kappab in Bronchoalveolar Cells of Smokers and Nonsmokers”. Molecular Medicine 7 (2001): 177-185.
  48. Heusch WL and Maneckjee R. “Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells”. Carcinogenesis 19 (1998): 551-556.
  49. Hirosumi J., et al. “A central, role for JNK in obesity and insulin resistance”. Nature 420 (2002): 333-336.
  50. Libert C. “Inflammation: A nervous connection”. Nature 421 (2003): 328-329.
  51. Savage S., et al. “Effects of cigarette smoke on the immune system”. Toxicology and Applied Pharmacology 111 (1991): 523-529.
  52. Wang H., et al. “Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation”. Nature 421 (2003): 384-388.
Citation: Alexandre Campos Moraes Amato. “Is Lipedema a Unique Entity?”. EC Clinical and Medical Case Reports 3.2 (2020): 01-07.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 26, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk